P/E ratio for Rhön-Klinikum (RHK.DE)
P/E ratio as of April 2024 (TTM): 33.1
According to Rhön-Klinikum's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 33.1326. At the end of 2022 the company had a P/E ratio of 40.3.
P/E ratio history for Rhön-Klinikum from 2009 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | 40.3 | 17.6% |
| 2021 | 34.2 | -95.17% |
| 2020 | 709 | 2538.17% |
| 2019 | 26.9 | -11.17% |
| 2018 | 30.3 | -46.3% |
| 2017 | 56.4 | 84.56% |
| 2016 | 30.5 | 31.33% |
| 2015 | 23.3 | 838.64% |
| 2014 | 2.48 | -92.77% |
| 2013 | 34.3 | 41.14% |
| 2012 | 24.3 | 86.46% |
| 2011 | 13.0 | -20.91% |
| 2010 | 16.5 | 3.1% |
| 2009 | 16.0 |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.